⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL79191 | 0.91 | NOS2 (0.33) | — | |
| SCHEMBL1845097 | 0.82 | — | — | |
| SCHEMBL1587660 | 0.80 | — | — | |
| SCHEMBL12678305 | 0.78 | — | — | |
| SCHEMBL10723117 | 0.78 | — | — | |
| SCHEMBL4609280 | 0.74 | — | — | |
| SCHEMBL3590968 | 0.74 | — | — | |
| SCHEMBL14142064 | 0.74 | — | — | |
| SCHEMBL5648243 | 0.73 | NOS2 (0.33) | — | |
| SCHEMBL8461226 | 0.72 | EPHX1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 468 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4511369-A1 | INDOLINE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | Mindset Pharma Inc. (CA) | 2025-02-26 | — | — | EP | claimed |
| EP-4511360-A1 | INDOLINE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | Mindset Pharma Inc. (CA) | 2025-02-26 | — | — | EP | claimed |
| WO-2023201421-A1 | INDOLINE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | MINDSET PHARMA INC. (CA) | 2023-10-26 | — | — | WO | claimed |
| WO-2023201423-A1 | INDOLINE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | MINDSET PHARMA INC. (CA) | 2023-10-26 | — | — | WO | claimed |
| US-20230049294-A1 | STEREOSELECTIVE PROCESS OF MANUFACTURE OF PURINE PHOSPHORAMIDATES | Atea Pharmaceuticals, Inc. (US) | 2023-02-16 | — | — | US | claimed |
| CN-115536660-A | Benzylamino-substituted heteropolycyclic compounds, compositions, formulations and uses thereof | 北京福元医药股份有限公司 | 2022-12-30 | — | — | CN | claimed |
| WO-2021216722-A1 | STEREOSELECTIVE PROCESS OF MANUFACTURE OF PURINE PHOSPHORAMIDATES | Atea Pharmaceuticals, Inc. (US) | 2021-10-28 | — | — | WO | claimed |
| US-10570088-B2 | Blood brain barrier-penetrating oximes for cholinesterase reactivation | HUMAN BIOMOLECULAR RES FOUNDATION (US) | 2020-02-25 | — | — | US | claimed |
| US-20170349538-A1 | Blood Brain Barrier-Penetrating Oximes for Cholinesterase Reactivation | Human BioMolecular Research Foundation (US) | 2017-12-07 | — | — | US | claimed |
| US-20140243517-A1 | METHODS OF PRODUCING C-ARYL GLUCOSIDE SGLT2 INHIBITORS | ASTRAZENECA AB (SE) | 2014-08-28 | — | — | US | claimed |
| US-20070238866-A1 | METHODS OF PRODUCING C-ARYL GLUCOSIDE SGLT2 INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2007-10-11 | — | — | US | claimed |
| EP-1581543-A2 | METHODS OF PRODUCING C-ARYL GLUCOSIDE SGLT2 INHIBITORS | Bristol-Myers Squibb Company (US) | 2005-10-05 | — | — | EP | claimed |
| WO-2005058246-A2 | METHOD FOR PREPARING RADIOLABELED THYMIDINE | MOLECULAR TECHNOLOGIES, INC. (US) | 2005-06-30 | — | — | WO | claimed |
| US-20050131224-A1 | Method for preparing radiolabeled thymidine | CTI PET SYSTEMS, INC. | 2005-06-16 | — | — | US | claimed |
| WO-2004063209-A2 | METHODS OF PRODUCING C-ARYL GLUCOSIDE SGLT2 INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2004-07-29 | — | — | WO | claimed |
| US-20040138439-A1 | inhibitors of sodium dependent glucose transporters found in the intestine and kidney (SGLT2), and more particularly to a process of producing such compounds, for example 1-C-(substituted diphenylmethane-3-yl)- beta -D-glucopyranose | ASTRAZENECA AB (SE) | 2004-07-15 | — | — | US | claimed |
| EP-0641346-B1 | 7'-AMINO-NAPHTHAZARIN ANTIBIOTIC DERIVATIVES | LEPETIT SPA (IT) | 1996-05-29 | — | — | EP | claimed |
| US-5475010-A | Vaginal infections | GRUPPO LEPETIT S.P.A. (IT) | 1995-12-12 | — | — | US | claimed |
| EP-0641346-A1 | 7'-AMINO-NAPHTHAZARIN ANTIBIOTIC DERIVATIVES. | LEPETIT SPA (IT) | 1995-03-08 | — | — | EP | claimed |
| WO-1993012115-A1 | 7'-AMINO-NAPHTHAZARIN ANTIBIOTIC DERIVATIVES | GRUPPO LEPETIT S.P.A. (IT) | 1993-06-24 | — | — | WO | claimed |